In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose

Ken S. Feldman; Kiran Sahasrabudhe; Michael D. Lawlor; Sarah L. Wilson; Charles H. Lang; William J. Scheuchenzuber

doi:10.1016/S0960-894X(01)00332-8

In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose

Ken S. Feldman, Kiran Sahasrabudhe, Michael D. Lawlor, Sarah L. Wilson, Charles H. Lang, William J. Scheuchenzuber

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Abstract

The naturally occurring gallotannin β-D-pentagalloylglucose (β-PGG) decreases tumor necrosis factor-alpha (TNF-α) output from human peripheral blood mononucleocytes exposed to lipopolysaccharide (LPS) by as much as 90% (vs control) at ∼5 μM concentration. A qualitatively similar but less pronounced effect (∼50% decrease) was observed in the serum of rats dosed with both LPS and β-PGG. These results may have relevance to therapies that target disease states characterized by an overproduction of TNF-α.

Original language	English (US)
Pages (from-to)	1813-1815
Number of pages	3
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	11
Issue number	14
DOIs	https://doi.org/10.1016/S0960-894X(01)00332-8
State	Published - Jul 23 2001

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0960-894X(01)00332-8

Cite this

@article{a77317a951584ae299fa598309343433,

title = "In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose",

abstract = "The naturally occurring gallotannin β-D-pentagalloylglucose (β-PGG) decreases tumor necrosis factor-alpha (TNF-α) output from human peripheral blood mononucleocytes exposed to lipopolysaccharide (LPS) by as much as 90% (vs control) at ∼5 μM concentration. A qualitatively similar but less pronounced effect (∼50% decrease) was observed in the serum of rats dosed with both LPS and β-PGG. These results may have relevance to therapies that target disease states characterized by an overproduction of TNF-α.",

author = "Feldman, {Ken S.} and Kiran Sahasrabudhe and Lawlor, {Michael D.} and Wilson, {Sarah L.} and Lang, {Charles H.} and Scheuchenzuber, {William J.}",

note = "Funding Information: The authors thank the National Institutes of Health (GM 35727 (KSF), GM 38032 (CHL)) for financial support of this work.",

year = "2001",

month = jul,

day = "23",

doi = "10.1016/S0960-894X(01)00332-8",

language = "English (US)",

volume = "11",

pages = "1813--1815",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

number = "14",

}

TY - JOUR

T1 - In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose

AU - Feldman, Ken S.

AU - Sahasrabudhe, Kiran

AU - Lawlor, Michael D.

AU - Wilson, Sarah L.

AU - Lang, Charles H.

AU - Scheuchenzuber, William J.

N1 - Funding Information: The authors thank the National Institutes of Health (GM 35727 (KSF), GM 38032 (CHL)) for financial support of this work.

PY - 2001/7/23

Y1 - 2001/7/23

N2 - The naturally occurring gallotannin β-D-pentagalloylglucose (β-PGG) decreases tumor necrosis factor-alpha (TNF-α) output from human peripheral blood mononucleocytes exposed to lipopolysaccharide (LPS) by as much as 90% (vs control) at ∼5 μM concentration. A qualitatively similar but less pronounced effect (∼50% decrease) was observed in the serum of rats dosed with both LPS and β-PGG. These results may have relevance to therapies that target disease states characterized by an overproduction of TNF-α.

AB - The naturally occurring gallotannin β-D-pentagalloylglucose (β-PGG) decreases tumor necrosis factor-alpha (TNF-α) output from human peripheral blood mononucleocytes exposed to lipopolysaccharide (LPS) by as much as 90% (vs control) at ∼5 μM concentration. A qualitatively similar but less pronounced effect (∼50% decrease) was observed in the serum of rats dosed with both LPS and β-PGG. These results may have relevance to therapies that target disease states characterized by an overproduction of TNF-α.

UR - http://www.scopus.com/inward/record.url?scp=0035939246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035939246&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(01)00332-8

DO - 10.1016/S0960-894X(01)00332-8

M3 - Article

C2 - 11459638

AN - SCOPUS:0035939246

SN - 0960-894X

VL - 11

SP - 1813

EP - 1815

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 14

ER -

In vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-α secretion by the gallotannin β-D-pentagalloylglucose

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this